Harmony Biosciences Ownership | Who Owns Harmony Biosciences?
Harmony Biosciences Ownership Summary
Harmony Biosciences is owned by 88.34% institutional investors, 11.62% insiders, and 0.04% retail investors. Valor management is the largest institutional shareholder, holding 19.76% of HRMY shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.15% of its assets in Harmony Biosciences shares.
HRMY Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Harmony Biosciences | 88.34% | 11.62% | 0.04% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Valor management | 11.22M | 19.76% | $338.45M |
Blackrock | 5.84M | 10.28% | $176.05M |
Fmr | 5.24M | 9.23% | $158.03M |
Vanguard group | 3.52M | 6.20% | $106.18M |
Vivo capital | 2.61M | 4.59% | $78.63M |
Pacer advisors | 2.51M | 4.42% | $75.71M |
State street | 1.27M | 2.24% | $38.42M |
Venbio partners | 1.04M | 1.82% | $31.24M |
Dimensional fund advisors lp | 956.78K | 1.69% | $28.87M |
Morgan stanley | 836.11K | 1.47% | $25.23M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Valor management | 11.22M | 74.43% | $338.45M |
Venbio partners | 1.04M | 13.49% | $31.24M |
Nan fung group | 368.67K | 11.87% | $11.12M |
Vivo capital | 2.61M | 7.26% | $78.63M |
Alphacentric advisors | 122.00K | 2.71% | $3.68M |
Cutter capital management, lp | 295.77K | 2.69% | $8.92M |
Capital management corp /va | 240.04K | 1.45% | $7.24M |
Tang capital management | 281.20K | 0.86% | $8.48M |
683 capital management | 295.00K | 0.67% | $8.90M |
Healthinvest partners ab | 34.90K | 0.64% | $1.05M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Cutter capital management, lp | 295.77K | 2.69% | 295.77K |
Goldman sachs group | 455.36K | 0.00% | 244.41K |
Lsv asset management | 578.25K | 0.04% | 243.10K |
American century companies | 681.54K | 0.01% | 238.14K |
Renaissance | 595.80K | 0.03% | 215.70K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Abrdn | - | - | -295.81K |
Nuveen asset management | 204.16K | 0.00% | -199.21K |
Schroder investment management group | 29.58K | 0.00% | -147.88K |
Healthinvest partners ab | 34.90K | 0.64% | -135.10K |
Vanguard group | 3.52M | 0.00% | -108.84K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Cutter capital management, lp | 295.77K | 2.69% | 295.77K | $8.92M |
Norges bank | 127.99K | 0.00% | 127.99K | $3.86M |
Squarepoint ops | 50.02K | 0.00% | 50.02K | $1.51M |
Hrt financial lp | 31.78K | 0.01% | 31.78K | $958.00K |
Verition fund management | 20.45K | 0.00% | 20.45K | $617.04K |
Sold Out
Holder | Change |
---|---|
Tfo-tdc | -1.00 |
Financial synergies wealth advisors | -5.00 |
Nelson, van denburg & campbell wealth management group | -6.00 |
Venturi wealth management | -30.00 |
Bell investment advisors | -32.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 219 | 4.78% | 50,151,794 | 2.75% | 88 | 1.31% | 104 | 14.29% | 76 | -5.00% |
Mar 31, 2024 | 209 | -6.70% | 48,809,647 | 2.10% | 82 | 1.29% | 91 | -21.55% | 80 | 5.26% |
Dec 31, 2023 | 224 | 7.69% | 47,804,048 | -3.08% | 79 | 1.18% | 116 | -0.85% | 76 | 33.33% |
Sep 30, 2023 | 208 | -2.35% | 49,324,058 | -5.08% | 82 | 1.09% | 117 | -0.85% | 57 | -12.31% |
Jun 30, 2023 | 213 | -4.48% | 51,964,344 | 1.00% | 86 | 1.17% | 118 | 2.61% | 65 | -18.75% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 2.37M | 4.15% | 13.34K |
Fidelity Growth Compy Commingled Pl O | 2.36M | 4.14% | - |
HBM Healthcare Investments AG Ord | 2.15M | 3.78% | - |
iShares Core S&P Small-Cap ETF | 1.91M | 3.35% | 2.00K |
Pacer US Small Cap Cash Cows 100 ETF | 1.90M | 3.33% | -489.00 |
Fidelity Growth Company Fund | 1.72M | 3.02% | -3.66K |
Vanguard Total Stock Mkt Idx Inv | 1.26M | 2.21% | 267.44K |
Vanguard Small Cap Index | 1.00M | 1.76% | 217.40K |
iShares Russell 2000 ETF | 778.49K | 1.36% | -1.75K |
Avantis US Small Cap Value ETF | 735.59K | 1.29% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 01, 2024 | Valor IV Pharma Holdings, LLC | - | Sell | $121.21M |
Nov 05, 2024 | Valor IV Pharma Holdings, LLC | - | Sell | $18.18M |
Nov 05, 2024 | Marshman Fund Trust II | - | Sell | $18.18M |
Nov 01, 2024 | Marshman Fund Trust II | - | Sell | $121.21M |
Oct 29, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | $870.02K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 6 |
2024 Q3 | - | 2 |
2024 Q2 | - | - |
2024 Q1 | - | 2 |
2023 Q4 | - | - |
HRMY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools